Key result
Serum proteomics identifies unique markers for primary MVD subtypes correlating with histopathological valve differences.
Why the study?
Mitral valve disease is the most common valvulopathy, but data regarding its molecular basis remain scarce.
Do serum proteomic profiles mirror the histopathological changes underlying different etiologies of primary mitral valve disease?
Population
300 patients with chronic primary MVD undergoing MV replacement
Comparison
Four etiologic subtypes: CMVD (n=81) vs RHVD (n=114) vs BD (n=70) vs FED (n=35)
Design
Observational discovery study with serum proteomics and histopathology
Authors
Loading...
Hypothesis-generating for proteomic subtyping in primary mitral valve disease; prospective validation needed before clinical use.
Do serum proteomic profiles mirror the histopathological changes underlying different etiologies of primary mitral valve disease?
Serum proteomic profiles correlate with specific histopathological changes in different etiologies of primary mitral valve disease, suggesting potential diagnostic biomarkers and therapeutic targets.
Garcia-Peña et al. (2025) studied this question. Serum proteomics identified unique markers for each primary mitral valve disease subtype, correlating with histopathological differences in valve composition and remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: